Literature DB >> 3131376

Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. I. Determination of isotretinoin and tretinoin and their 4-oxo metabolites in plasma.

R Wyss1, F Bucheli.   

Abstract

A fully automated gradient high-performance liquid chromatographic method for the determination of isotretinoin, tretinoin and their 4-oxo metabolites in plasma was developed, using the column-switching technique. After dilution with an internal standard solution containing 20% acetonitrile, 0.5 ml of the sample was injected onto a precolumn (17 X 4.6 mm I.D.), filled with C18 Corasil 37-53 micron. Proteins and polar plasma components were washed out using 1% ammonium acetate-acetonitrile (9:1, v/v) as mobile phase 1. After valve switching, the retained components were transferred to the analytical column in the backflush mode, separated by gradient elution and detected at 360 nm by UV detection. Using two coupled reversed-phase columns (125 mm long), the separation of cis and trans isomers was possible, and all four compounds could be quantified down to 2 ng/ml of plasma. The inter-assay precision in the concentration range 20-100 ng/ml was between 1.0 and 4.7% for all compounds.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131376     DOI: 10.1016/s0378-4347(00)81107-x

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Serum retinoids in retinitis pigmentosa patients treated with vitamin A.

Authors:  G A Fex; S Andréasson; B Ehinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

2.  Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in Escherichia coli.

Authors:  M Berggren Söderlund; G Johannesson; G Fex
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

3.  Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate. Possible relation to teratogenicity.

Authors:  G Fex; K Larsson; A Andersson; M Berggren-Söderlund
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.